Related Experiment Video
Updated: Mar 12, 2026
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Current Expectations for Cardiac Transplantation in Patients With Congenital Heart Disease
James K Kirklin1, Waldemar F Carlo2, F Bennett Pearce2
1Division of Cardiothoracic Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, USA jkirklin@uab.edu.
Insights
Pediatric heart transplants for congenital heart disease are complex but survival rates are improving. Advances in mechanical circulatory support and managing long-term complications like allograft failure are key to better outcomes.
Area of Science:
- Cardiology
- Pediatric Surgery
- Transplantation Immunology
Background:
- Congenital heart disease (CHD) is a leading indication for pediatric heart transplantation, representing 40% of cases.
- Patients with CHD present unique challenges including sensitization, pulmonary vascular resistance, and hepatic reserve considerations.
Purpose of the Study:
- To review the challenges and outcomes of heart transplantation in pediatric patients with congenital heart disease.
- To identify risk factors, bridging strategies, and long-term survival determinants.
Main Methods:
- Review of current literature and clinical practices in pediatric heart transplantation for CHD.
- Analysis of risk stratification, mechanical circulatory support, and management of post-transplant complications.
Main Results:
- The initial 3 months post-transplant carry the highest risk for CHD patients, after which survival is comparable to those transplanted for cardiomyopathy.
- Single ventricle physiology and failing Fontan circulations represent the highest risk categories.
- Chronic allograft failure and allograft vasculopathy remain significant barriers to long-term survival.
Conclusions:
- Despite inherent complexities, pediatric heart transplantation for CHD has seen significant improvements in survival.
- Enhanced mechanical circulatory support and strategies to mitigate chronic rejection are crucial for further progress.
Abstract:
Congenital heart disease accounts for 40% of pediatric heart transplants and presents unique challenges to the transplant team. Suitability for transplantation is defined in part by degree of sensitization, pulmonary vascular resistance, and hepatic reserves. The incremental transplant risk for patients with congenital heart disease occurs within the first 3 months, after which survival is equivalent to transplantation for cardiomyopathy. Single ventricle with prior palliation, and especially the failing Fontan, carry the highest risk for transplantation and are least amenable to bridging with mechanical circulatory support. More effective bridging to transplant with mechanical circulatory support will require improvements in the adverse event profile of available pumps and the introduction of miniaturized continuous flow technology. The major barriers to routine long-term survival are chronic allograft failure and allograft vasculopathy. Despite these many challenges, continuing improvements in the care of pediatric heart transplant patients have pushed the median posttransplant survival past 15 years for children and to 20 years for infants.
Related Concept Videos
01:28Kidney Transplant I: Introduction
01:29Cardiomyopathy V: Interprofessional Care
01:24Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...